- Home
- RCKY vs IKT Comparison
RCKY vs IKT Comparison
Compare RCKY & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKY | IKT |
|---|---|---|
| Founded | 1932 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.3M | 181.9M |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RCKY | IKT |
|---|---|---|
| Price | $29.07 | $1.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | 56.1K | ★ 365.2K |
| Earning Date | 10-28-2025 | 11-14-2025 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ 53.66 | N/A |
| EPS | ★ 2.74 | N/A |
| Revenue | ★ $470,314,000.00 | N/A |
| Revenue This Year | $7.09 | N/A |
| Revenue Next Year | $4.27 | N/A |
| P/E Ratio | $10.61 | ★ N/A |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $11.93 | $1.33 |
| 52 Week High | $33.40 | $4.20 |
Technical Indicators
Market Signals| Indicator | RCKY | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 44.30 |
| Support Level | $28.68 | $1.43 |
| Resistance Level | $30.80 | $1.57 |
| Average True Range (ATR) | 1.11 | 0.11 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 16.21 | 23.08 |
Price Performance
Historical ComparisonAbout RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.